NewsNew Coronavirus Test Harnesses RT-LAMP TechnologyMax Planck Institute for Evolutionary Anthropology | March 8, 2021 The new RT-LAMP method uses patient-collected gargle lavage samples, producing results in less than an hour
NewsStudy Highlights Need for Variant-Resistant COVID-19 TreatmentsVanderbilt University Medical Center | March 5, 2021 Highly neutralizing monoclonal antibody "cocktails" can effectively neutralize target SARS-CoV-2 variants
NewsAutomated NGS Platform Can Accurately Screen Thousands for COVID-19Lunenfeld-Tanenbaum Research Institute | March 5, 2021 The new robotics platform can screen thousands of SARS-CoV-2 samples at once
NewsIndoors, Outdoors, 6 Feet Apart? Transmission Risk of COVID-19 QuantifiedColorado State University | March 4, 2021 A new study quantifies the dynamics of how aerosols like SARS-CoV-2 travel when airborne
NewsAntibodies to Common Cold Coronaviruses Do Not Protect against SARS-CoV-2University of Pennsylvania School of Medicine | February 10, 2021 Antibodies that react to both ordinary coronaviruses and SARS-CoV-2 do not neutralize the COVID-19-causing virus
NewsAt-Home Swabs Are Effective at Diagnosing InfectionsAmerican Society for Microbiology | February 2, 2021 A systematic review and meta-analysis shows that at-home swabs are just as accurate as those taken by health care workers
NewsT Cells Mount Attacks against Many SARS-CoV-2 Targets—Including New VariantLa Jolla Institute for Immunology | January 27, 2021 By attacking the virus from many angles, T cells have the tools to recognize different SARS-CoV-2 variants
Applications & ProductsSponsoredOptimize COVID-19 Sample Accessioning and Processing WorkflowsClinical Lab Manager | January 27, 2021 Discover what labs have learned since the beginning of the pandemic to optimize your lab's COVID-19 workflows
NewsStudy Finds Genetic Clues to Pneumonia Risk and COVID-19 DisparitiesVanderbilt University Medical Center | January 21, 2021 The results may help identify patients with COVID-19 at greatest risk for pneumonia, enabling early interventions
NewsRapid Blood Test Identifies COVID-19 Patients at High Risk of Severe DiseaseWashington University School of Medicine | January 18, 2021 The blood test measures levels of mitochondrial DNA, a sign of cell death and hyperinflammation